These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14531831)

  • 41. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
    Mertz DP
    MMW Munch Med Wochenschr; 1978 Oct; 120(42):1387-90. PubMed ID: 101792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Approach to the treatment of hyperuricemia.
    Poon SH; Hall HA; Zimmermann B
    Med Health R I; 2009 Nov; 92(11):359-62. PubMed ID: 19999894
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of hyperuricemia and gout].
    Gröbner W; Walter-Sack I
    Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988
    [No Abstract]   [Full Text] [Related]  

  • 44. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R; Bresnik W; Müller MM
    Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Gout: physiopathology, diagnosis, course, treatment].
    Chazerain P; Ziza JM
    Rev Prat; 1998 Sep; 48(13):1453-6. PubMed ID: 10050628
    [No Abstract]   [Full Text] [Related]  

  • 46. [The treatment of the kidney of the gouty patient].
    Louyot P
    Sem Ther; 1964 Oct; 40(8):482-5. PubMed ID: 5878572
    [No Abstract]   [Full Text] [Related]  

  • 47. Astilbin attenuates hyperuricemia and ameliorates nephropathy in fructose-induced hyperuricemic rats.
    Chen L; Lan Z; Zhou Y; Li F; Zhang X; Zhang C; Yang Z; Li P
    Planta Med; 2011 Nov; 77(16):1769-73. PubMed ID: 21614752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Drug-induced hypouricemia: pathophysiology and application to the hyperuricemia with life style related disease].
    Hisatome I; Ogino K; Igawa O; Shigemasa C
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():403-9. PubMed ID: 12629757
    [No Abstract]   [Full Text] [Related]  

  • 49. To study the efficacy of Losartan on urinary uric acid excretion in Thiazide induced hyperuricemic and hypertensive patients.
    Khan M; Khan RA; Islam F; Laghari J; Jamali SN
    Pak J Pharm Sci; 2011 Oct; 24(4):583-7. PubMed ID: 21959825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gout: on the brink of novel therapeutic options for an ancient disease.
    Bieber JD; Terkeltaub RA
    Arthritis Rheum; 2004 Aug; 50(8):2400-14. PubMed ID: 15334451
    [No Abstract]   [Full Text] [Related]  

  • 51. Utilization patterns of antihyperuricemic agents following safety announcement on allopurinol and benzbromarone by Taiwan Food and Drug Administration.
    Cheng CL; Chao PH; Hsu JC; Weng MM; On AW; Yang YH
    Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):309-13. PubMed ID: 24307655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical trials of uric acid lowering for coronary heart disease risk reduction.
    Simon JA
    Am J Med; 2006 Apr; 119(4):e5; author reply e7. PubMed ID: 16564763
    [No Abstract]   [Full Text] [Related]  

  • 53. Familial juvenile hyperuricaemic nephropathy.
    Bleyer AJ; Hart TC
    QJM; 2003 Nov; 96(11):867-8. PubMed ID: 14566042
    [No Abstract]   [Full Text] [Related]  

  • 54. [Usefulness of combination treatment using allopurinol and benzbromarone for gout and hyperuricemia accompanying renal dysfunction: kinetic analysis of oxypurinol].
    Ohno I; Okabe H; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Gomi H; Ichida K; Hosoya T
    Nihon Jinzo Gakkai Shi; 2008; 50(4):506-12. PubMed ID: 18546882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pharmacology of hypouricemic effect of benzbromarone.
    Sinclair DS; Fox IH
    J Rheumatol; 1975 Dec; 2(4):437-45. PubMed ID: 1206675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Uninterrupted therapy of hyperuricemia and gout].
    Schilling F
    Reumatizam; 1971; 18(3):79-82. PubMed ID: 5097291
    [No Abstract]   [Full Text] [Related]  

  • 57. Riparoside B and timosaponin J, two steroidal glycosides from Smilax riparia, resist to hyperuricemia based on URAT1 in hyperuricemic mice.
    Wu XH; Zhang J; Wang SQ; Yang VC; Anderson S; Zhang YW
    Phytomedicine; 2014 Sep; 21(10):1196-201. PubMed ID: 24908163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Gout and hyperuricaemia--should both be treated?].
    Uhlig T
    Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2878-80. PubMed ID: 14600714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
    Decaux G; Soupart A; Musch W; Hannotier P; Prospert F
    Clin Nephrol; 1998 Oct; 50(4):262-5. PubMed ID: 9799074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of hyperuricemia in gout and renal insufficiency with benziodarone].
    Richet G; Cottet J; Amiel C; Leroux-Robert C; Podevin R
    Presse Med (1893); 1966 May; 74(24):1247-9. PubMed ID: 5936081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.